Truvada (Tenofovir/FTC)
| Brand Name: |
Truvada |
| Generic Name: |
Emtricitabine + tenofovir disoproxil
fumarate, FTC/TDF |
| Adult Single Dose: |
One tablet containing 200 mg FTC
and 300 mg TDF (once a day) |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
NRTI |
|
|
|
The Basics
- Patient Assistance Programs (Regularly Updated)
Having problems paying for Truvada? Visit Gilead's patient assistance program page.
From Gilead Sciences, Inc.
- An Overview of Truvada (Tenofovir/FTC) (September 13, 2012)
From AIDSinfo
- Treatment to Prevent HIV Infection (PrEP) (August 19, 2012)
To read PDF, click here.
From AIDS InfoNet
- Truvada (Tenofovir + Emtricitabine) (August 19, 2012)
To read PDF, click here.
From AIDS InfoNet
- Truvada (March/April 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- FAQs About Truvada (Tenofovir/FTC) (January 27, 2012)
From The Body's "Ask the Experts" Forums
- Patient Information About Truvada (Tenofovir/FTC) (PDF) (July 2011)
From Gilead Sciences, Inc.
- CDC Trials: Pre-Exposure Prophylaxis for HIV Prevention (February 2011)
To read PDF, click here.
From U.S. Centers for Disease Control and Prevention
- Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: Promoting Safe and Effective Use in the United States (February 2011)
To read PDF, click here.
From U.S. Centers for Disease Control and Prevention
- Truvada (Viread + Emtriva) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- Understanding Two New Once-a-Day Combinations: Truvada and Epzicom (November/December 2004)
Daniel S. Berger, M.D., reviews issues of drug concentrations, adherence and resistance.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- New Fixed-Dose Once-a-Day Starting Regimens: Interview With Cal Cohen, M.D. (October 26, 2004)
A leading AIDS physician looks at the advantages and disadvantages of Epzicom and Truvada for those who are first starting antiretroviral treatment.
In AIDS Treatment News, from AIDS Treatment News
On TheBodyPRO.com
News
- A Gay Man Discusses His Decision to Begin PrEP -- Part Three (February 27, 2013)
From PositiveLite.com
- A Gay Man Discusses His Decision to Begin PrEP -- Part Two (February 20, 2013)
From PositiveLite.com
 A Gay Man Discusses His Decision to Begin PrEP -- Part One (February 13, 2013)
From PositiveLite.com
 Truvada: Troubles Ahead? A Blog Entry by Dave R. (October 5, 2012)
"This story about Truvada, being used as a prevention tool, just gives me the chills. It's as if they just haven't taken into account the foibles of human nature when it comes to doing what you're supposed to do."
From TheBody.com
- PrEP Approved, Insurance Coverage Unclear (August 8, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- World Health Organization Endorses HIV Medication for Prevention (July 23, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Maryland: New HIV Prevention Drug May Not Be for Everyone (July 19, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- UNAIDS Welcomes U.S. Approval of Drug to Stop HIV (July 18, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- NPR Reports on Brazilian Clinical Trial of Truvada as Prevention Strategy (July 18, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- The FDA Gives Truvada as PreP the Official Okay (July 17, 2012)
In Housing Works AIDS Issues Update, from Housing Works
VIEW ALL ARTICLES
Research
- University of South Florida to Join National Study of HIV Prevention Pill in Young Men (January 2, 2013)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Truvada's Efficacy as PrEP Reaffirmed (November/December 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
On TheBodyPRO.com
- Truvada Drug Trials Signal "Turning Point" in AIDS Epidemic (July 13, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Studies Show Success, Highlight Challenges of PrEP Strategy (July 12, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Global Campaign for Microbicides Statement on the Discontinuation of the FEM-PrEP Trial (April 19, 2011)
From Global Campaign for Microbicides
- Researchers to Wind Down HIV Prevention Trial in Women After Interim Results Find Drug Not Offering Protection From HIV (April 19, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Scientists Halt FEM-PrEP Study in Africa (April 18, 2011)
In Housing Works AIDS Issues Update, from Housing Works
- The FEM-PrEP HIV Prevention Study and Its Implications for NIAID Research (April 18, 2011)
From U.S. National Institute of Allergy and Infectious Diseases
- Results of FEM-PrEP Clinical Trial Examining Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among Heterosexual Women (April 18, 2011)
From U.S. Centers for Disease Control and Prevention
 PrEP Ineffective for Women? Study on Truvada for HIV Prevention Is Unexpectedly Cut Short: A Blog Entry by Myles Helfand (April 18, 2011)
From TheBody.com
VIEW ALL ARTICLES
|
|
Advertisement
|
Email
Glossary
